← All blog posts

6 Critical Questions to Ask When Researching Sales Enablement Tools for Your MedTech Brand

Avoid costly platform mistakes that hurt medical device sales. Learn the 6 critical questions MedTech companies must ask when researching specialized sales enablement tools.

Published Sep 22, 2025

Most sales enablement platforms were built for general B2B sales organizations. Medical device companies using them discover quickly that “general B2B” doesn’t account for 6–12 month sales cycles, multi-stakeholder clinical buying committees, FDA compliance requirements, or reps presenting in hospital environments where pulling out a laptop isn’t realistic.

The result is a platform that looks good in a demo and disappoints in the field. Before signing a contract, these six questions will cut through the marketing copy and reveal whether a tool was actually built for how MedTech sells.

1. Does This Platform Offer True Content Control, or Is It Just a Repository?

Many platforms — including some well-known names in the sales enablement space — function as organized file storage. They house your materials but allow reps to download and modify them freely. The moment a rep downloads a presentation and changes the messaging, colors, or clinical claims, you’ve lost control of your brand story in the field.

True content control means reps can access, present, and share materials without ever downloading or modifying the underlying files.Look for platforms that prevent downloading, lock brand elements and clinical claims, allow approved customization within guardrails, and maintain audit trails for compliance. If a vendor can’t demonstrate how they prevent unauthorized modification at the field level, assume they can’t.

2. Can This Platform Handle Your Multi-Stakeholder, Multi-Stage Sales Process?

A medical device sales cycle isn’t one presentation — it’s a sequence of different conversations with different stakeholders over months.Initial cold outreach, clinical demonstrations, ROI discussions with administrators, follow-up when prospects go quiet, and post-sale trainingall require different content for different audiences.

Ask vendors how they organize content around actual sales stages rather than generic folder structures. Ask how a rep would find the right presentation for a specific type of meeting in under 60 seconds. If the answer involves navigating folder hierarchies or memorizing file names, the platform wasn’t designed around how reps actually work.

3. Is This Platform Genuinely Mobile-First, or Just Mobile-Compatible?

There’s a meaningful difference between “mobile-compatible” (files can be downloaded on a phone) and “mobile-first” (content is designed to load and display perfectly on any device without downloading).Healthcare professionals review vendor content between surgeries and during rounds— they’re not sitting at a desk.

Ask vendors to demonstrate their platform on a phone in a clinical scenario. Does it load instantly? Does the layout adapt to the screen without pinching and zooming? Can the rep share it via text and have it load immediately for the prospect? Anything less than a genuinely seamless mobile experience means your content will fail in the moments it matters most.

4. Does It Include MedTech-Specific Features Beyond Generic CMS?

Generic content management systemsdon’t account for the specific content types that medical device sales require: 3D mechanism-of-action animations, interactive ROI calculators for administrators, procedure-specific clinical modules, post-sale practice development content. Ask vendors specifically about each of these — and ask to see them demonstrated in a realistic MedTech context, not a generic B2B demo.

Platforms that have built these capabilities natively will demonstrate them fluently. Platforms that haven’t will describe how they could be configured or integrated. The difference matters for implementation speed and long-term cost of ownership.

5. What Do the Analytics Actually Tell You — and Who Acts on Them?

Most platforms offer analytics. The more important question is what those analytics measure and what happens with the data afterward.

Surface-level analytics tell you what content was opened and by whom. Meaningful analytics for MedTech tell you which clinical data sections held a physician’s attention, which presentations correlate with closed deals, which content your distributor reps are actually using versus ignoring, and which materials need to be updated based on engagement patterns.

Ask vendors to show you a real analytics dashboard — not a screenshot, but a live demonstration. Then ask: what do your customers typically do with this data? Who on your team helps them act on it? A platform that produces a dashboard and leaves interpretation to you is only solving half the problem. The best vendors — and the most scalable systems — pair analytics with a team that uses the data to keep your content improving over time.

6. Is This a Platform or a Partnership — and Does That Difference Matter to You?

This is the question most evaluations never reach, and it’s often the most consequential one.

Every platform on this list sells software. You pay for a license, receive a login, and your team figures out the rest. Implementation is on you. Content strategy is on you. Keeping the library current, onboarding new reps, acting on analytics — all on you. Support exists, but the ongoing work of making the platform actually perform lives inside your organization.

That model works if you have dedicated sales ops, an in-house content team, and the bandwidth to actively manage a platform. Most MedTech companies — especially lean ones — don’t.

A managed service model works differently. Rather than selling you software and stepping back, a true managed service partner builds your system, creates and maintains your content, trains your team, and actively uses performance data to refine what gets built next. When you launch a new product, they handle the content. When a rep leaves and a new one joins, they handle the onboarding. When engagement data shows that a particular presentation isn’t resonating with physicians, they rebuild it.

Ask every vendor you evaluate: what does your ongoing involvement look like after go-live? The ones selling pure SaaS will describe support tiers and ticket systems. The ones operating as a managed service will describe a team.

For MedTech companies without the internal resources to run a platform themselves, this distinction isn’t a preference — it’s the difference between a system that performs and one that collects dust.

Using These Questions in Practice

Structure your vendor evaluation around these six questions explicitly. Ask each vendor to demonstrate — not describe — their answer in a scenario relevant to your specific sales process. Vendors who have genuinely solved for MedTech will welcome the specificity. Those who haven’t will revert to generic answers and promises about configuration.

The goal isn’t to find the platform with the longest feature list. It’s to find the one that will actually work in the field — for your reps, your content, your compliance requirements, and your customers.

What Does a Platform That Answers All Six Look Like?

Most platforms in this space can answer four or five of these questions adequately. Very few can answer all six — and almost none can answer question six the way a purpose-built MedTech managed service can.

Nuvue's MedTech sales enablement platform is built to answer all six.

Nuvue was built specifically for medical device companies. Brand-locked presentations that reps can assemble but not modify. Mobile-responsive content delivered as a link, not a file. Customer training portals that track engagement after the sale. Analytics your team actively uses — because Nuvue’s team uses them too, to keep your content sharp and your reps prepared.

Most MedTech companies are fully operational in under two weeks. And unlike a SaaS platform that hands you a login and a training video, we handle the entire setup — and stay involved after.

See how Nuvue answers all six → Book a 30-minute demo

Frequently asked

Questions readers also ask.

Q: Why should MedTech companies be skeptical of standard sales enablement platforms?

Standard platforms are built for horizontal B2B sales organizations and require significant customization to accommodate the clinical complexity, regulatory requirements, and field dynamics of medical device selling. That customization is expensive, takes time, and often still doesn’t fully address MedTech-specific needs. The result is a platform that requires ongoing workarounds rather than one that works out of the box for your team.

‍

Q: What are the six most critical questions to ask when evaluating a MedTech sales enablement tool?

Ask: Does this platform offer true content control or just file storage? Can it handle our multi-stakeholder, multi-stage sales process? Is it genuinely mobile-first or just mobile-compatible? Does it include MedTech-specific features beyond generic CMS? What does ongoing support and account management look like? And can it scale as our team grows without becoming more complex? These six questions reveal more than any feature comparison chart.

‍

Q: How does asking the right questions during evaluation protect a MedTech company from a bad platform investment?

Vendors who can’t answer MedTech-specific questions with specificity reveal that they haven’t solved for your environment. A vendor who responds to compliance questions with vague generalities, or who can’t demonstrate mobile performance in a clinical workflow scenario, is likely to deliver a platform that disappoints in the field. Good questions during evaluation protect you from discovering those gaps after go-live.

‍

Q: What should a MedTech company do if no platform perfectly meets all six criteria?

Prioritize your most acute pain points and identify which criteria gaps are acceptable versus disqualifying. Compliance and mobile performance are typically non-negotiable; deep CRM integration might be a nice-to-have. Document trade-offs explicitly, negotiate for roadmap commitments on critical gaps, and set clear success criteria for the first 90 days that will reveal whether the platform is delivering on its promises.

‍

Q: How should a MedTech sales enablement evaluation team be structured?

Include representatives from sales (frontline reps and leadership), marketing, compliance, and IT. Each group will identify different gaps: reps surface field usability issues; marketing evaluates content governance; compliance scrutinizes approval workflows; IT assesses integration and security. A decision made without input from all four stakeholders almost always misses at least one critical requirement that creates problems post-implementation.

Get demo

End the chaos. See how MedTech sells.

A 30-minute walkthrough, tailored to your product and your sales cycle.